Citigroup
APMD

Citigroup’s Apnimed Inc APMD Stock Holding History

Citigroup’s Portfolio APMD Stock Details APMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.1K Buy
+600
New +$16.1K ﹤0.01% 5118

Other funds holding APMD

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Asset Planning Inc
Asset Planning Inc Cypress, California $152M AUM 19.47% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Clearstead Advisors
Clearstead Advisors Cleveland, Ohio $10.8B AUM 17.88% 1-Year Est. Return

Citigroup's APMD Position: Q3 2026 in Review

Citigroup opened a new position in Apnimed Inc (APMD) in Q3 2026: 600 shares worth $13.1K. The stake represents ﹤0.01% of the portfolio and ranks #5118 among its holdings.

15 funds tracked by Wall St. Rank hold APMD as of Q3 2026.

  • Citigroup held 600 shares of Apnimed Inc worth $13.1K as of Q3 2026.
  • Apnimed Inc was a new Citigroup position in Q3 2026.
  • Apnimed Inc made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5118 holding.
  • 15 funds tracked by Wall St. Rank held Apnimed Inc as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.